Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot phase IV trial of oral IMUNOR for prevention of COVID-19
2020-005524-11Phase 4Completed
- Sponsor
- University Hospital Ostrava
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of inosine pranobex in coronavirus disease 2019 (COVID-19), sponsored by University Hospital Ostrava. Primary endpoint: Number of patients with clinical manifestations corresponding to SARS-CoV-2 infection. Started Dec 2020; status: completed.
02
Drugs
inosine pranobex
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-005524-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-005524-11.